SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

06 Aug 2024 Evaluate
A decrease in the sales to Rs. 1628.99 millions was observed for the quarter ended June 2024. The sales stood at Rs. 1795.41 millions during the similar quarter previous year.The Net Profit of the company registered a slight decline of -14.38% to Rs. 377.77  millions from Rs. 441.21 millions.Operating profit for the quarter ended June 2024 decreased to 529.78 millions as compared to 640.19 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1628.99 1795.41 -9.27 1628.99 1795.41 -9.27 7115.98 7209.82 -1.30
Other Income 87.15 50.63 72.13 87.15 50.63 72.13 288.60 239.56 20.47
PBIDT 529.78 640.19 -17.25 529.78 640.19 -17.25 2580.90 2430.45 6.19
Interest 0.27 0.48 -43.75 0.27 0.48 -43.75 1.61 13.59 -88.15
PBDT 529.51 639.71 -17.23 529.51 639.71 -17.23 2481.86 2416.86 2.69
Depreciation 34.82 60.50 -42.45 34.82 60.50 -42.45 280.91 250.74 12.03
PBT 494.69 579.21 -14.59 494.69 579.21 -14.59 2200.95 2166.12 1.61
TAX 116.92 138.00 -15.28 116.92 138.00 -15.28 563.44 565.84 -0.42
Deferred Tax 19.42 -6.00 -423.67 19.42 -6.00 -423.67 21.44 7.84 173.47
PAT 377.77 441.21 -14.38 377.77 441.21 -14.38 1637.51 1600.28 2.33
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 32.52 35.66 -8.79 32.52 35.66 -8.79 36.27 33.71 7.59

Blue Jet Healthcare Share Price

407.75 5.15 (1.28%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×